Gilead Sciences advertising spend, FY2025

Gilead Sciences (GILD) reported $1B of advertising expense for the fiscal year ended Dec 31, 2025. That is 3.4% of revenue of $29.4B. Up 15.1% from FY2024.

Ad spend, FY2025
$1B
year ended Dec 31, 2025
Change vs prior year
+15.1%
vs FY2024
Share of revenue
3.4%
of $29.4B revenue
Rank by ad spend
#65
of 458 companies

Key facts

  • Ad spend is 1.7x its FY2015 level ($601M), faster than revenue (0.9x).
  • FY2025 is the highest year on file, going back to FY2008.
  • Largest increase +81.9% in FY2014; largest cut -7.5% in FY2021.
  • Ad spend has risen 4 years in a row.
  • Ad spend is 3.4% of revenue, up from 3.2% in FY2020.
  • Gilead Sciences spends more on advertising than 86% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is below the median of 4.5%.

Ad spend by fiscal year

$0 $250M $500M $750M $1B FY2008 (ended 2008-12-31): $96.2M FY2009 (ended 2009-12-31): $108M FY2010 (ended 2010-12-31): $117M 2010 FY2011 (ended 2011-12-31): $117M FY2012 (ended 2012-12-31): $160M FY2013 (ended 2013-12-31): $216M 2013 FY2014 (ended 2014-12-31): $393M FY2015 (ended 2015-12-31): $601M FY2016 (ended 2016-12-31): $618M 2016 FY2017 (ended 2017-12-31): $600M FY2018 (ended 2018-12-31): $587M FY2019 (ended 2019-12-31): $784M 2019 FY2020 (ended 2020-12-31): $795M FY2021 (ended 2021-12-31): $735M FY2022 (ended 2022-12-31): $778M 2022 FY2023 (ended 2023-12-31): $826M FY2024 (ended 2024-12-31): $869M FY2025 (ended 2025-12-31): $1B 2025 $1B

Ad spend as % of revenue

0% 1% 2% 3% 4% FY2008 (ended 2008-12-31): 1.8% FY2009 (ended 2009-12-31): 1.5% FY2010 (ended 2010-12-31): 1.5% 2010 FY2011 (ended 2011-12-31): 1.4% FY2012 (ended 2012-12-31): 1.6% FY2013 (ended 2013-12-31): 1.9% 2013 FY2014 (ended 2014-12-31): 1.6% FY2015 (ended 2015-12-31): 1.8% FY2016 (ended 2016-12-31): 2.0% 2016 FY2017 (ended 2017-12-31): 2.3% FY2018 (ended 2018-12-31): 2.7% FY2019 (ended 2019-12-31): 3.5% 2019 FY2020 (ended 2020-12-31): 3.2% FY2021 (ended 2021-12-31): 2.7% FY2022 (ended 2022-12-31): 2.9% 2022 FY2023 (ended 2023-12-31): 3.0% FY2024 (ended 2024-12-31): 3.0% FY2025 (ended 2025-12-31): 3.4% 2025 3.4%

Ad spend in context, FY2025

Advertising was 17.3% of selling, general and administrative expense. Research and development spending was 5.8x advertising. Advertising equalled 10.0% of operating income.

Advertising $1B AdvertisingExpense
Selling, general and administrative $5.8B ad spend = 17.3%
Research and development $5.8B R&D = 5.8x ad spend
Operating income $10B ad spend = 10.0%
Net income $8.5B

Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.

History

Download CSV
Fiscal year Period end Ad spend YoY Revenue Ad / revenue Tag Filing
FY2025 Dec 31, 2025 $1B +15.1% $29.4B 3.4% AdvertisingExpense 10-K Feb 24, 2026
FY2024 Dec 31, 2024 $869M +5.2% $28.8B 3.0% AdvertisingExpense 10-K Feb 24, 2026
FY2023 Dec 31, 2023 $826M +6.2% $27.1B 3.0% AdvertisingExpense 10-K Feb 24, 2026
FY2022 Dec 31, 2022 $778M +5.9% $27.3B 2.9% AdvertisingExpense 10-K Feb 28, 2025
FY2021 Dec 31, 2021 $735M -7.5% $27.3B 2.7% AdvertisingExpense 10-K Feb 23, 2024
FY2020 Dec 31, 2020 $795M +1.4% $24.7B 3.2% AdvertisingExpense 10-K Feb 22, 2023
FY2019 Dec 31, 2019 $784M +33.6% $22.4B 3.5% AdvertisingExpense 10-K Feb 23, 2022
FY2018 Dec 31, 2018 $587M -2.2% $22.1B 2.7% AdvertisingExpense 10-K Feb 25, 2021
FY2017 Dec 31, 2017 $600M -2.9% $26.1B 2.3% AdvertisingExpense 10-K Feb 25, 2020
FY2016 Dec 31, 2016 $618M +2.8% $30.4B 2.0% AdvertisingExpense 10-K Feb 26, 2019
FY2015 Dec 31, 2015 $601M +52.9% $32.6B 1.8% AdvertisingExpense 10-K Feb 27, 2018
FY2014 Dec 31, 2014 $393M +81.9% $24.9B 1.6% AdvertisingExpense 10-K Feb 27, 2017
FY2013 Dec 31, 2013 $216M +35.0% $11.2B 1.9% AdvertisingExpense 10-K Feb 24, 2016
FY2012 Dec 31, 2012 $160M +37.2% $9.7B 1.6% AdvertisingExpense 10-K Feb 25, 2015
FY2011 Dec 31, 2011 $117M +0.1% $8.4B 1.4% AdvertisingExpense 10-K Feb 25, 2014
FY2010 Dec 31, 2010 $117M +7.8% $7.9B 1.5% AdvertisingExpense 10-K Feb 27, 2013
FY2009 Dec 31, 2009 $108M +12.4% $7B 1.5% AdvertisingExpense 10-K Feb 23, 2012
FY2008 Dec 31, 2008 $96.2M n/a $5.3B 1.8% AdvertisingExpense 10-K Feb 28, 2011

Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank.

What the figure is

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Compared with similar spenders

The 6 companies closest to Gilead Sciences in latest-year ad spend.

Rank Company Ad spend Ad / revenue YoY Fiscal year
63 Kimberly-Clark $1B 6.2% -9.1% FY2025
64 Macy's $1B 4.4% -9.2% FY2026
65 Gilead Sciences $1B 3.4% +15.1% FY2025
66 Marriott International $999M 3.8% +0.6% FY2025
67 Lowe's $978M 1.1% +6.2% FY2026
68 Carnival $972M 3.7% +5.1% FY2025
69 CVS Health $970M 0.2% -1.9% FY2025

Full ranking of 458 companies · Biggest increases #136

Questions

How much does Gilead Sciences spend on advertising?

Gilead Sciences spent $1B on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 24, 2026.

What percentage of revenue does Gilead Sciences spend on advertising?

3.4% of revenue in fiscal 2025 ($1B against $29.4B). The median across the 458 companies tracked is 4.5%.

Is Gilead Sciences spending more on advertising?

Yes. Ad spend rose 15.1% in fiscal 2025 from fiscal 2024. It has risen 4 years in a row.

How does Gilead Sciences rank by advertising spend?

#65 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.

Does Gilead Sciences spend more on advertising than on R&D?

No. In fiscal 2025 it spent $5.8B on research and development and $1B on advertising.

What does Gilead Sciences's advertising figure include?

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Company and source

Filing
10-K for FY2025, filed Feb 24, 2026
Accession number
0000882095-26-000006
Company
GILEAD SCIENCES, INC., CIK 882095, SIC 2836 (Biological Products, (No Diagnostic Substances))
Headquarters
Foster City, CA
Incorporated in
DE
Fiscal year ends
December 31
Listed on
Nasdaq
SEC filer status
Large accelerated filer
Data
SEC EDGAR XBRL company facts, retrieved Nov 18, 2026. Methodology.
Cite
Gilead Sciences advertising spend, FY2008-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 24, 2026), retrieved Nov 18, 2026. https://io.trudov.com/company/gilead-sciences/advertising-spend/
Download
CSV, all years · CSV, all 458 companies